from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3845/-

LFCtreatmentdescriptionclass of inhibitor

0.586

Amikacinug/mL Amikacintranslation

0.549

Cap5-10ug/mL Capreomycintranslation

0.359

Rox10-50 ug/mL Roxithromycintranslation

0.174

SM2-5 ug/mL Streptomycintranslation

-0.258

Tet5-10 ug/mL Tetracyclinetranslation

0.013

Rif0.2-5ug/mL Rifampicintranscription

1.231

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.478

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.777

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.079

CPZ10-50 ug/mL Chlorpromazinerespiration

0.879

Clofazimine10-13 ug/mL Clofaziminerespiration

0.355

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.812

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.048

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.423

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.253

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.140

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.396

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.411

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.618

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.533

KCN5-20 ug/mL Potassium cyaniderespiration

-0.695

NaN30.2-2 mM Sodium aziderespiration

-1.405

Nigericin50 uM Nigericinrespiration

0.898

TRC10-150 ug/mL Triclosanrespiration

1.500

TRZ10-25 ug/mL Thioridazinerespiration

1.275

Valinomycin0.5-10 uM Valinomycinrespiration

-2.521

ZnSO42 mM ZnSO4respiration

-1.090

menadione6-10 ug/mL Menadionerespiration

0.186

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.212

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.219

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.430

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.246

NRP_1Non-replicating persistence stage 1dosRassociated

-0.075

Amp0.2mg/mL AmpicillincellWall

-0.352

Cephalexin20-100 ug/mL CephalexincellWall

-0.260

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.131

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.639

EMB10-20 ug/mL EthambutolcellWall

-0.740

Eta12-40 ug/mL EthionamidecellWall

-1.263

INH0.2-0.4 ug/mL IsoniazidcellWall

0.122

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.439

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.009

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.041

BZA0.12 mg/mL BenzamidearomaticAmides

0.227

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.157

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.026

H2O24 mM hydrogen peroxideDNAdamaging

0.528

Levo10 ug/mL LevofloxacinDNAdamaging

-0.314

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.514

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.456

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.566

UVUV-irradiationDNAdamaging

2.548

ARP41-4 ug/mL Antitubercular compound ARP4?

0.141

Antimycin12.5-50 ug/mL Antimycin A?

-0.385

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.449

PA_110-50 ug/mL Antitubercular compound PA-1?

0.010

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.096

PA8240.2-2 ug/mL PA-824?

-0.352

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.580

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.051

Verapamil50 uM Verapamil?

-1.382

mercaptoethanol2 mM 2-Mercaptoethanol?

0.365

methoxatin10-20 ug/mL Methoxatin?